Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-12

Clinical Trial Update: Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating curcumin and cholecalciferol in previously untreated stage 0-II chronic lymphocytic leukemia or small lymphocytic lymphoma has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cholecalciferol (Vitamin D3)
  • Curcumin (curcumin)

Snippet

Sponsor: Paolo Caimi, MD | Conditions: Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2024-04-12